Intellectual Property India Publishes Patent Application for 'Vector Encoding Rod-Derived Cone Viability Factor And Human Igk Signal Sequence' Filed by Pharma Cinq, Llc

MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202517094260 A) filed by Pharma Cinq, Llc, Rockville, U.S.A., on Sept. 30, for 'vector encoding rod-derived cone viability factor and human igk signal sequence.'

Inventor(s) include Luo, Tianci; Liput, Daniel; and Liang, Fong Qi.

The application for the patent was published on Oct. 31, under issue no. 44/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to nucleic acids coding for and capable of expressing a full-length rod-derived cone viability factor (RdCVF) and human IgK signal sequence and viral vectors containing these nucleic acids. The invention also relates to compositions and pharma...